ArticleKidney international2017

Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.

Vicki J Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.